By RESEARCH TRIANGLE PARK
Insider knowledge and understanding positions BioPharma Consultants with edge to implement actionable business strategies
RESEARCH TRIANGLE PARK, NC - Cutting through the clutter of existing consultants, an innovative company has sprung forth to offer insider knowledge and comprehensive strategy and business development services to pharmaceutical and biotechnology companies worldwide.
Dr. Robert Keefer and Leisa Dennehy, the principals of BioPharma Consultants, bring extensive global industry experience managing all aspects of a product or service’s life cycle, including technology and commercial assessment, development planning, pre- and post-launch brand or market planning, life cycle/generic defense planning, and business and corporate development.
“We’ve been on our client’s side of the desk and we know how critical it is to have consulting resources who actually know our needs, understand the industry and can deliver results,” says Dennehy, a 14-year veteran of the commercial side of multinational organizations such as Procter & Gamble and Glaxo Wellcome.
What would the consumer gain by using your product or service? This could be tangible, like a free gift; prestige, power or fame. But remember: you must be able to make good on that promise, so don’t offer anything unreasonable.
Co-founder Keefer melds business/financial/marketing acumen with a science/technology background. He has founded a number of successful companies and held executive positions at pharmaceutical firms such as SmithKline-Beecham. “Our mission is to use our experience to catapult pharmaceutical and biotechnology companies to new points of insight and action that drive competitiveness and sustainable business success,” he said.
BioPharma Consultants differentiates itself by serving as an extension of its clients’ internal teams, helping companies translate technical features into commercial benefits or brand positioning to provide a competitive edge. Its clients include GlaxoSmithKline, Oxford Glycosciences Ltd (UK), BioSignia Inc., Nanogen, Apothogen Inc. and the American Chemistry Council.
“BioPharma Consultants offers benefits that you just don’t get with a traditional consulting firm,” said Rob Nauman, director of Global E-Business Marketing, GlaxoSmithKline. “Typically, it can take six months just to get a consultant up to speed. But BioPharma Consultants was able to immediately grasp what we needed, develop very sophisticated recommendations and get to work executing the strategies and tactics.”
Most recently, the firm proved its mettle by winning a contract from BioSignia Inc. to help launch its newly formed Pharmaceutical Technology Group, a business unit created earlier this year to develop pharmaceutical and biotech industry applications of its patented Synthesis Analysis technology.
“Leisa Denney and Bob Keefer, through their extraordinary industry insight and experience, are able to help us articulate our technology in language that’s meaningful to the right people in pharma,” said Joe Chimera, Ph.D., vice president for corporate development and head of the Pharmaceutical Technology Group of BioSignia Inc. “They represent a powerful strategic, scientific, and marketing force, and we’re very excited to be working with them.”
About BioPharma Consultants, Ltd.
Headquartered in Research Triangle Park, BioPharma Consultants, Ltd. is a management consulting firm specializing in marketing, strategy and business development services for biotech and pharmaceutical companies worldwide. For more information on BioPharma Consultants, please visit the firm’s website at www.biopharma-consultants.com or call +1-919-960-7075